2 completed, 2 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Terminated 1 |
Follow LOU064: new trials by email Literature Review of LOU064 trials Research Report on LOU064
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR) LOU064, Placebo - Papulopustular Rosacea | Phase 2 | Recruiting | Novartis Pharmaceuticals | 100 | 2026-07-30 | 2026-11-10 |
| Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria Remibrutinib, Placebo - Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Phase 2 | Recruiting | Novartis Pharmaceuticals | 44 | 2025-05-22 | 2026-09-28 |
| Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts LOU064, placebo - Allergy, Peanut | Phase 2 | Completed | Novartis Pharmaceuticals | 76 | 2022-10-12 | 2026-06-12 |
| An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU LOU064 - Chronic Spontaneous Urticaria | Phase 2 | Completed | Novartis Pharmaceuticals | 229 | 2019-10-24 | 2024-06-20 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome Remibrutinib, Placebo - Sjögren Syndrome | Phase 2 | Terminated | Novartis Pharmaceuticals | 73 | 2019-07-12 | 2023-01-30 |
Chronic Urticaria (2) · Arthritis (1) · Autoimmune Diseases (1) · Chronic Inducible Urticaria (1) · Cold Urticaria (1) · Connective Tissue Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Familial dermographism (1) · Food Hypersensitivity (1) · Immune System Diseases (1) · Joint Diseases (1) · Lacrimal Apparatus Diseases (1) · Mouth Diseases (1) · Musculoskeletal Diseases (1)
United States (5) · Spain (4) · Germany (3) · Belgium (2) · Bulgaria (2) · Canada (2) · China (2) · Denmark (2) · France (2) · Hungary (2) · Poland (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Czechia (1)
2018 (1), 2019 (1), 2025 (1)